by Shantel Irwin, CEO Arthritis Action

Corks were flying on June 18th 2015 for me and my team at Arthritis Action as we officially launched with our new name, new look and new direction.
The last 12 months have been transformational for our charity. After more than a year of research, review, redesign and reform, Arthritis Action finally relaunched at The King’s Fund to an audience of more than 100 members and guests from across the musculoskeletal health sector.
We were delighted to welcome so many friends and colleagues at our event, which gave us the chance to outline our rationale for change, what we stand for, what we do and where we’re heading.…
Read more of this article
by Stuart Blackman, CEO of BackCare



by Ella Vine, Chief Executive, FibroAction It was a pleasure to attend last week’s ARMA parliamentary reception, an event with expert speakers and healthcare professionals on the subject of musculoskeletal conditions. The event was well attended and it was good to see that some MPs are genuinely interested in the cause and support the 2015 ARMA Manifesto. Lord Hunt, the Deputy Leader of the Opposition, has spoken about the challenges lying ahead of us to improve the diagnosis and care of MSK conditions and addressed all six points of ARMA’s Manifesto.…
by Dr. Alan Nye, President Primary Care Rheumatology Society, Executive Director, Pennine MSK Partnership Ltd.
by Laura Boothman, Policy Manager at Arthritis Research UK
by Dr Adam Al-Kashi, Head of Research & Education, BackCare
by Jann Landles, Hon Secretary, Vasculitis UK